Profile of Metastatic Bone Disease among Oncologic Patients at Tikur Anbessa Specialized Hospital from July 2022 – June 2024
No Thumbnail Available
Date
2024-10-10
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa University
Abstract
Background: Most cancer deaths are not due to primary tumors rather as a result of the metastatic events. Patients with bone metastasis may experience skeletal complications, such as pathological fractures, hypercalcaemia, neurologic symptoms and uncontrolled pain requiring bone surgery and/or radiotherapy, which are collectively called skeletal-related events (SREs). These skeletal related events seriously affect patient’s quality of life and contribute to the poor prognosis of patients. The purpose of this study was to assess the profiles of metastatic bone disease among patients with systemic malignancies and the determinant factors which affect patient’s quality of life.
Methods: This retrospective cohort study included patients diagnosed with skeletal metastasis between July 2022 and June 2024 in Oncology and Orthopedics departments of TASH. During the 2 years period, 222 patients were diagnosed with skeletal metastasis of which only 144 patients were selected for the study based on the inclusion and exclusion criteria. Data were collected from patient’s charts using structured questionnaire. Data collected included patient demographics and clinical data. The performance status of patients at the initial presentation was assessed using v ECOG grading system. Collected data were computed to SPSS statistics version 27. Descriptive analysis was done and categorical variables were expressed in numbers and percentages, continuous variables were expressed in mean and standard deviations. P value of less than 0.05 was considered statistically significant in multivariate analysis. Ethical approval was obtained from the Addis Ababa University Orthopedics and Clinical Oncology Department ethical review board.
Results: This study analyzed data from 144 patients diagnosed with metastatic bone disease over a two-year period. These patients were selected from an initial group of 222 due to having complete medical records. The study population consisted of more women (65.28%) than men (34.72%), with a mean age of 50.8 years (± 1.1 years). Breast cancer accounts nearly half of the primary cancer (49.3 %), followed by prostate cancer (18.1%), lung cancer (12.5%), GI cancer (6.94%) and thyroid cancer (6.25%). Most of the skeletal metastasis were osteolytic and predominantly involves the vertebrae, pelvic girdle, proximal femur, shoulder girdle and proximal humerus. Majority of patients got multimodal treatment where as 38.6% of patients did not get any form of treatment to the skeletal metastasis. The presence of visceral metastasis and metastatic bone disease from prostate and GI origin significantly affects the patient’s performance status.
Conclusion: In summary, metastatic bone disease could occur even in young patients and clinical suspicion is paramount important. Within this study, breast and prostate carcinomas were found to be the most frequent primary sources of metastatic bone disease. Our study findings were consistent with other similar studies but prospective study with larger sample size is recommended.
Keywords: Metastatic bone disease, skeletal related events, visceral metastasis, ECOG
Description
Keywords
Metastatic bone disease skeletal related events visceral metastasis ECOG